Copyright Reports & Markets. All rights reserved.

Global Nicotinamide Mononucleotide (NMN) Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Nicotinamide Mononucleotide (NMN) Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Type
    • 1.2.2 Content ＜ 98%
    • 1.2.3 Content ≥ 98%
  • 1.3 Market by Application
    • 1.3.1 Global Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application
    • 1.3.2 Health Care Products
    • 1.3.3 Cosmetics
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Nicotinamide Mononucleotide (NMN) Production

  • 2.1 Global Nicotinamide Mononucleotide (NMN) Production Capacity (2016-2027)
  • 2.2 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2016 VS 2021 VS 2027
  • 2.3 Global Nicotinamide Mononucleotide (NMN) Production by Region
    • 2.3.1 Global Nicotinamide Mononucleotide (NMN) Historic Production by Region (2016-2021)
    • 2.3.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Production by Region (2022-2027)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan
  • 2.8 Hong Kong

3 Global Nicotinamide Mononucleotide (NMN) Sales in Volume & Value Estimates and Forecasts

  • 3.1 Global Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2016-2027
  • 3.2 Global Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2016-2027
  • 3.3 Global Nicotinamide Mononucleotide (NMN) Revenue by Region: 2016 VS 2021 VS 2027
  • 3.4 Global Top Nicotinamide Mononucleotide (NMN) Regions by Sales
    • 3.4.1 Global Top Nicotinamide Mononucleotide (NMN) Regions by Sales (2016-2021)
    • 3.4.2 Global Top Nicotinamide Mononucleotide (NMN) Regions by Sales (2022-2027)
  • 3.5 Global Top Nicotinamide Mononucleotide (NMN) Regions by Revenue
    • 3.5.1 Global Top Nicotinamide Mononucleotide (NMN) Regions by Revenue (2016-2021)
    • 3.5.2 Global Top Nicotinamide Mononucleotide (NMN) Regions by Revenue (2022-2027)
  • 3.6 North America
  • 3.7 Europe
  • 3.8 Asia-Pacific
  • 3.9 Latin America
  • 3.10 Middle East & Africa

4 Competition by Manufactures

  • 4.1 Global Nicotinamide Mononucleotide (NMN) Supply by Manufacturers
    • 4.1.1 Global Top Nicotinamide Mononucleotide (NMN) Manufacturers by Production Capacity (2020 VS 2021)
    • 4.1.2 Global Top Nicotinamide Mononucleotide (NMN) Manufacturers by Production (2016-2021)
  • 4.2 Global Nicotinamide Mononucleotide (NMN) Sales by Manufacturers
    • 4.2.1 Global Top Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2016-2021)
    • 4.2.2 Global Top Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2016-2021)
    • 4.2.3 Global Top 10 and Top 5 Companies by Nicotinamide Mononucleotide (NMN) Sales in 2020
  • 4.3 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers
    • 4.3.1 Global Top Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2016-2021)
    • 4.3.2 Global Top Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2016-2021)
    • 4.3.3 Global Top 10 and Top 5 Companies by Nicotinamide Mononucleotide (NMN) Revenue in 2020
  • 4.4 Global Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.5.3 Global Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution
  • 4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type
    • 5.1.1 Global Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2016-2021)
    • 5.1.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2022-2027)
    • 5.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2016-2027)
  • 5.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Type
    • 5.2.1 Global Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2016-2021)
    • 5.2.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2022-2027)
    • 5.2.3 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2016-2027)
  • 5.3 Global Nicotinamide Mononucleotide (NMN) Price by Type
    • 5.3.1 Global Nicotinamide Mononucleotide (NMN) Price by Type (2016-2021)
    • 5.3.2 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2022-2027)

6 Market Size by Application

  • 6.1 Global Nicotinamide Mononucleotide (NMN) Sales by Application
    • 6.1.1 Global Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2016-2021)
    • 6.1.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2022-2027)
    • 6.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2016-2027)
  • 6.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Application
    • 6.2.1 Global Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2016-2021)
    • 6.2.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2022-2027)
    • 6.2.3 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2016-2027)
  • 6.3 Global Nicotinamide Mononucleotide (NMN) Price by Application
    • 6.3.1 Global Nicotinamide Mononucleotide (NMN) Price by Application (2016-2021)
    • 6.3.2 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2022-2027)

7 North America

  • 7.1 North America Nicotinamide Mononucleotide (NMN) Market Size by Type
    • 7.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2027)
    • 7.1.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2027)
  • 7.2 North America Nicotinamide Mononucleotide (NMN) Market Size by Application
    • 7.2.1 North America Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2027)
    • 7.2.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2027)
  • 7.3 North America Nicotinamide Mononucleotide (NMN) Sales by Country
    • 7.3.1 North America Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2027)
    • 7.3.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2027)
    • 7.3.3 U.S.
    • 7.3.4 Canada

8 Europe

  • 8.1 Europe Nicotinamide Mononucleotide (NMN) Market Size by Type
    • 8.1.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2027)
    • 8.1.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2027)
  • 8.2 Europe Nicotinamide Mononucleotide (NMN) Market Size by Application
    • 8.2.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2027)
    • 8.2.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2027)
  • 8.3 Europe Nicotinamide Mononucleotide (NMN) Sales by Country
    • 8.3.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2027)
    • 8.3.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2027)
    • 8.3.3 Germany
    • 8.3.4 France
    • 8.3.5 U.K.
    • 8.3.6 Italy
    • 8.3.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Market Size by Type
    • 9.1.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2027)
    • 9.1.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2027)
  • 9.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Market Size by Application
    • 9.2.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2027)
    • 9.2.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2027)
  • 9.3 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales by Region
    • 9.3.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales by Region (2016-2027)
    • 9.3.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2027)
    • 9.3.3 China
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 India
    • 9.3.7 Australia
    • 9.3.8 Taiwan
    • 9.3.9 Indonesia
    • 9.3.10 Thailand
    • 9.3.11 Malaysia
    • 9.3.12 Philippines

10 Latin America

  • 10.1 Latin America Nicotinamide Mononucleotide (NMN) Market Size by Type
    • 10.1.1 Latin America Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2027)
    • 10.1.2 Latin America Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2027)
  • 10.2 Latin America Nicotinamide Mononucleotide (NMN) Market Size by Application
    • 10.2.1 Latin America Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2027)
    • 10.2.2 Latin America Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2027)
  • 10.3 Latin America Nicotinamide Mononucleotide (NMN) Sales by Country
    • 10.3.1 Latin America Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2027)
    • 10.3.2 Latin America Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2027)
    • 10.3.3 Mexico
    • 10.3.4 Brazil
    • 10.3.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Size by Type
    • 11.1.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2027)
    • 11.1.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2027)
  • 11.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Market Size by Application
    • 11.2.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2027)
    • 11.2.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2027)
  • 11.3 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales by Country
    • 11.3.1 Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2016-2027)
    • 11.3.2 Middle East and Africa Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2027)
    • 11.3.3 Turkey
    • 11.3.4 Saudi Arabia
    • 11.3.5 U.A.E

12 Corporate Profiles

  • 12.1 GeneHarbor
    • 12.1.1 GeneHarbor Corporation Information
    • 12.1.2 GeneHarbor Overview
    • 12.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Description
    • 12.1.5 GeneHarbor Related Developments
  • 12.2 Herbalmax
    • 12.2.1 Herbalmax Corporation Information
    • 12.2.2 Herbalmax Overview
    • 12.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Product Description
    • 12.2.5 Herbalmax Related Developments
  • 12.3 Genex Formulas
    • 12.3.1 Genex Formulas Corporation Information
    • 12.3.2 Genex Formulas Overview
    • 12.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Description
    • 12.3.5 Genex Formulas Related Developments
  • 12.4 Shinkowa Pharmaceutical
    • 12.4.1 Shinkowa Pharmaceutical Corporation Information
    • 12.4.2 Shinkowa Pharmaceutical Overview
    • 12.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product Description
    • 12.4.5 Shinkowa Pharmaceutical Related Developments
  • 12.5 Maac10 Formulas
    • 12.5.1 Maac10 Formulas Corporation Information
    • 12.5.2 Maac10 Formulas Overview
    • 12.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Description
    • 12.5.5 Maac10 Formulas Related Developments
  • 12.6 Bontac
    • 12.6.1 Bontac Corporation Information
    • 12.6.2 Bontac Overview
    • 12.6.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Bontac Nicotinamide Mononucleotide (NMN) Product Description
    • 12.6.5 Bontac Related Developments
  • 12.7 EffePharm
    • 12.7.1 EffePharm Corporation Information
    • 12.7.2 EffePharm Overview
    • 12.7.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.7.4 EffePharm Nicotinamide Mononucleotide (NMN) Product Description
    • 12.7.5 EffePharm Related Developments
  • 12.8 Zhejiang Jiahua Pharmchemical Co., Ltd.
    • 12.8.1 Zhejiang Jiahua Pharmchemical Co., Ltd. Corporation Information
    • 12.8.2 Zhejiang Jiahua Pharmchemical Co., Ltd. Overview
    • 12.8.3 Zhejiang Jiahua Pharmchemical Co., Ltd. Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Zhejiang Jiahua Pharmchemical Co., Ltd. Nicotinamide Mononucleotide (NMN) Product Description
    • 12.8.5 Zhejiang Jiahua Pharmchemical Co., Ltd. Related Developments
  • 12.9 CELFULL
    • 12.9.1 CELFULL Corporation Information
    • 12.9.2 CELFULL Overview
    • 12.9.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.9.4 CELFULL Nicotinamide Mononucleotide (NMN) Product Description
    • 12.9.5 CELFULL Related Developments
  • 12.10 Kindomway
    • 12.10.1 Kindomway Corporation Information
    • 12.10.2 Kindomway Overview
    • 12.10.3 Kindomway Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Kindomway Nicotinamide Mononucleotide (NMN) Product Description
    • 12.10.5 Kindomway Related Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
  • 13.2 Nicotinamide Mononucleotide (NMN) Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Nicotinamide Mononucleotide (NMN) Production Mode & Process
  • 13.4 Nicotinamide Mononucleotide (NMN) Sales and Marketing
    • 13.4.1 Nicotinamide Mononucleotide (NMN) Sales Channels
    • 13.4.2 Nicotinamide Mononucleotide (NMN) Distributors
  • 13.5 Nicotinamide Mononucleotide (NMN) Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 14.1 Nicotinamide Mononucleotide (NMN) Industry Trends
  • 14.2 Nicotinamide Mononucleotide (NMN) Market Drivers
  • 14.3 Nicotinamide Mononucleotide (NMN) Market Challenges
  • 14.4 Nicotinamide Mononucleotide (NMN) Market Restraints

15 Key Finding in The Global Nicotinamide Mononucleotide (NMN) Study

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Content ＜ 98%
    Content ≥ 98%

    Segment by Application
    Health Care Products
    Cosmetics
    Others

    By Company
    GeneHarbor
    Herbalmax
    Genex Formulas
    Shinkowa Pharmaceutical
    Maac10 Formulas
    Bontac
    EffePharm
    Zhejiang Jiahua Pharmchemical Co., Ltd.
    CELFULL
    Kindomway

    Production by Region
    North America
    Europe
    China
    Japan
    Hong Kong

    Consumption by Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Buy now